Help us: Donate
Follow us on:
×

Menu

Back

Tag: Alex Zhavoronkov

Deep Longevity
Today, we have a bit more positive news with the announcement that Deep Longevity has added LifeHub and LifeClinic to its network of longevity-focused companies. This company plans to use multiple AI-based biological aging clocks to test a variety of longevity interventions, including supplements, drugs, and lifestyle choices. Teaming up to offer longevity healthcare This...
Longevity Therapeutics banner
We continue our coverage of Longevity Therapeutics 2021 and bring you part 2 of day 1. Read the first article of the series here. Dr. Steven Braithwhite - Chief Scientific Officer, Alkahest Steven Braithwhite from Alkahest gave an update on the company’s ongoing clinical trials. Alkahest has been sifting plasma proteome in search for proteins...
Physician meeting
There is a huge disconnect between aging research in the lab and medical practitioners who directly deal with patients. Aging research labs around the world are often years ahead of overall medical knowledge, and this is a serious problem in the drive to create a comprehensive longevity ecosystem. To address this, there needs to be...
Taisho Pharmaceutical logo
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on AI-powered drug discovery focused on identifying molecules to remove problematic senescent cells. Why we Age: Cellular SenescenceAs your body ages, more...
Young.ai logo
A new app created by Hong Kong-based Deep Longevity might help you stay in your prime longer, keep your mind sharp, and maintain habits that keep your biological age lower than your chronological age. Introducing Young.ai It has been an increasing trend in recent years for companies to develop health and fitness apps that track...
ICD
Few things in aging research are ever straightforward, and today's topic is no exception, as two researchers enjoy some back and forth regarding whether and how the World Health Organization (WHO) should recognize the aging processes as a disease. Proposing a new framework to facilitate development of rejuvenation therapies Back in November 2019, an international...